QUILLIVANT
NextWave Pharmaceuticals, Inc.
Application Filed: 2011-05-27
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85332659 |
| Registration Number | 4392798 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Cathy A. Kodroff |
| Attorney Docket Number | TRIS-QUILLIV |
| Law Office Assigned | L60 |
| Employee Name | KON, ELISSA GARBER |
Timeline
| 2011-05-27 | Application Filed |
| 2011-11-01 | Published for Opposition |
| 2013-01-14 | Date of First Use |
| 2013-07-24 | Location: PUBLICATION AND ISSUE SECTION |
| 2013-08-27 | Status: Live/Registered |
| 2013-08-27 | Trademark Registered |
| 2019-02-06 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  NextWave Pharmaceuticals, Inc. |
| Address | Suite 150 20450 Stevens Creek Boulevard Cupertino DE 95014 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2011-05-31 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-06-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2011-09-14 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2011-09-15 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2011-09-15 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2011-09-15 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2011-09-15 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-09-15 | 8 CNSA P: |
| ASSIGNED TO LIE | 2011-09-27 | 9 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-09-28 | 10 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-11-01 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-11-01 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2011-12-27 | 13 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2012-06-26 | 14 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2012-07-20 | 15 AITU A:Allowance for Publication |
| EXTENSION 1 FILED | 2012-06-26 | 16 EXT1 S: |
| EXTENSION 1 GRANTED | 2012-07-20 | 17 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2012-07-21 | 18 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2012-12-13 | 19 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2012-12-13 | 20 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2012-12-20 | 21 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2012-12-20 | 22 EXT2 S: |
| EXTENSION 2 GRANTED | 2013-01-17 | 23 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-01-18 | 24 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2013-06-21 | 25 EEXT I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2013-06-24 | 26 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2013-07-12 | 27 AITU A:Allowance for Publication |
| EXTENSION 3 FILED | 2013-06-21 | 28 EXT3 S: |
| EXTENSION 3 GRANTED | 2013-07-18 | 29 EX3G S: |
| USE AMENDMENT FILED | 2013-06-24 | 30 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2013-07-18 | 31 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-07-19 | 32 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2013-07-19 | 33 CNPR P: |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2013-07-24 | 34 REGV O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2013-07-25 | 35 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2013-08-27 | 36 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2018-08-27 | 37 REM1 E:E-Mail |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2018-10-03 | 38 ASCK I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-02-05 | 39 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-02-05 | 40 ARAA I:Incoming Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2019-07-16 | 41 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2019-08-26 | 42 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2019-08-26 | 43 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2019-08-26 | 44 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2022-08-27 | 45 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2022-10-07 | 46 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-04-20 | 47 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2023-04-20 | 48 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2023-04-20 | 49 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2023-04-20 | 50 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 QUILLIVANT 85332659 4392798 Live/Registered |
NextWave Pharmaceuticals, Inc. 2011-05-27 |
 QUILLIVANT 85332657 not registered Dead/Abandoned |
NextWave Pharmaceuticals, Inc. 2011-05-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 